Inovalon to Co-Chair and Present at The 7th Annual RISE and HEA Summit - WICU12/WSEE Erie, PA News, Sports, Weather and Events

Inovalon to Co-Chair and Present at The 7th Annual RISE and HEA Summit

Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.

SOURCE Inovalon, Inc.

Executives Provide Insights on the Implementation of Quality Improvement and Data Accuracy Strategies for Plans to Compete in the Health Insurance Exchange (HIX) Marketplace

BOWIE, Md., Feb. 28, 2013 /PRNewswire/ --Inovalon, Inc., a leading provider of data-driven healthcare solutions, announced its participation as Co-Chair at The Risk Adjustment Initiative and Society for Education (RISE) and Healthcare Education Associates (HEA) 7^th Annual Summit on March 10-12, 2013 in Nashville, Tennessee.

(Logo: http://photos.prnewswire.com/prnh/20120605/MM17779LOGO )

The Annual RISE Summit features the latest strategies for integrating commercial health insurance exchange marketplace quality, risk score and revenue management, a multitude of educational sessions, and opportunities to learn from and network with hundreds of health insurance professionals. At the conference, Inovalon executives will provide their insights on the essential steps health plans must take to succeed within a quality-driven and value-based healthcare exchange.

"The health insurance exchange marketplaces represent opportunities the industry faces in the years ahead," said Dan Rizzo, Chief Innovations Officer at Inovalon. "We are proud to partner with RISE in this forum to highlight the impact that data-driven solutions have in improving healthcare outcomes and economics."

"This will be our best-attended RISE Summit yet," said Lori Medlen, Executive Director of RISE. "The industry's shown great interest in this event and given the new health insurance exchange marketplace and the continual push to integrate Medicare quality ratings and revenue management, we will be seeing hundreds attend this year."

Jason Z. Rose, Senior Vice President of Business Development at Inovalon, will chair the three-day conference, which includes topics on the similarities and differences between Medicare and Commercial Risk Adjustment. He will also chair the conference's Risk Adjustment track. This is Mr. Rose's third year speaking at the summit and second year as Chair.

Troy Dinkel, M.D., Chief Product Officer at Inovalon, will speak on the theme of "Practical Strategies for Risk Adjustment in the Exchanges." His presentation will focus on strategies to meet the challenges that health plans face as they participate in health insurance exchange marketplaces, including the need to ensure risk score accuracy as a critical factor for plans' financial viability and regulatory compliance. Dr. Dinkel's session will be held on Monday, March 11 at 2:40 p.m. (ET).

About Inovalon, Inc.

Inovalon, Inc. is a leading technology-enabled healthcare solutions provider focused on the importance of healthcare data and its ability to drive dramatic, objective improvement in clinical and quality outcomes, care management and financial performance throughout the healthcare community. Proprietary healthcare datasets, aggregation and analysis capabilities, combined with a national infrastructure of leading-edge technology, clinical prowess and deep human resources, empower Inovalon's advanced generation of healthcare assessment and improvement through highly informed solutions. Driven by data, Inovalon uniquely identifies gaps in care, quality, data integrity, and financial performance ­-- while also bringing to bear the resources to resolve them. This differentiating combination provides a powerful capability suite, touching more than 540,000 physicians, 220,000 clinical facilities, and more than 120 million Americans, driving high-value impact, improving the quality and economics for health plans, hospitals, physicians, patients, and researchers. Please visit www.inovalon.com for more information.

©2012 PR Newswire. All Rights Reserved.